NCT05229887

Brief Summary

Tracheal intubation remains a common procedure in the neonatal intensive care unit (NICU) and the delivery room (DR). Current guidelines recommend Estimation of correct endotracheal tube (ETT) insertion Our hospital policy recommends to estimate the correct depth (cm) of tube placement by measuring the nasal-ear-tragus length using the "7-8-9 rule" when the endotracheal tube is placed orally. Using this formula an infant weighing 1kg would be intubated to a depth of 7cm, a 2kg infant to a depth of 8cm, and a 3kg infant to a depth of 9cm from the upper lip. With the new 2015 guidelines, ETT depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm or by using the "initial endotracheal tube insertion depth" table. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear. However, studies using NTL reported that using this technique only resulted in correct ETT placement in 56% of cases. Every ETT has markings on the tube, which are called vocal cord markings, which are to be used to provide a guidance to how deep to place the ETT into the trachea. There has been npc study to compare the vocal cord markings with the current approach of NTL. The current study aims to determine if the use of vocal cord markings during intubation increases percentage of correct endotracheal tube placement compared to NTL in preterm and term infants.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 8, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

July 4, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

September 19, 2024

Status Verified

April 1, 2022

Enrollment Period

2.5 years

First QC Date

January 31, 2022

Last Update Submit

September 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of endotracheal tubes correctly placed within the trachea

    within 30 minutes after endotracheal intubation

Secondary Outcomes (9)

  • Mortality in the Neonatal Intensive Care Unit

    0-200 days

  • Necrotizing Enterocolitis

    0-200 days

  • Patent Ductus Arteriosus

    0-200 days

  • Intraventricular hemorrhage all grades

    0-200 days

  • Bronchopulmonary Dysplasia at

    36 weeks corrected gestational age

  • +4 more secondary outcomes

Study Arms (2)

Nostril-Tragus-Length

ACTIVE COMPARATOR
Procedure: Nostril-Tragus-Length

Vocal cord markings

EXPERIMENTAL
Procedure: Vocal cord marking

Interventions

Endotracheal tube depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear.

Nostril-Tragus-Length

The endotracheal tube has markings on the tube, which are called vocal cord markings, which will be used to provide a guidance to how deep to place the ETT into the trachea.

Vocal cord markings

Eligibility Criteria

AgeUp to 3 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All infants (term and preterm) born at The Royal Alexandra Hospital who require endotracheal intubation in the delivery room or/and Neonatal Intensive Care Unit will be eligible.

You may not qualify if:

  • Infants will be excluded if their parents refuse to give consent to this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Alexandra Hospital

Edmonton, Alberta, T5H 3V9, Canada

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Georg Schmolzer

    University of Alberta

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2022

First Posted

February 8, 2022

Study Start

July 4, 2022

Primary Completion

December 31, 2024

Study Completion

March 31, 2025

Last Updated

September 19, 2024

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

Investigators can contact the PI to discuss to use the collected data

Shared Documents
STUDY PROTOCOL, ICF, CSR

Locations